Research Topic · Peer-Reviewed

Ace Inhibitor Therapy

ACE inhibitor therapy is the use of angiotensin-converting enzyme inhibitors, a class of medicines that lower blood pressure and protect the heart and kidneys. ACE inhibitors block the enzyme that converts angiotensin I into angiotensin II, a hormone that narrows blood vessels and promotes fluid retention. By reduci…

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 5× across the literature 🔖 ISSN 2329-9487 🗓 Reviewed July 2026

Overview

ACE inhibitor therapy is the use of angiotensin-converting enzyme inhibitors, a class of medicines that lower blood pressure and protect the heart and kidneys. ACE inhibitors block the enzyme that converts angiotensin I into angiotensin II, a hormone that narrows blood vessels and promotes fluid retention. By reducing angiotensin II, these drugs relax blood vessels, decrease blood pressure, and ease the workload on the heart. They are widely prescribed for hypertension, heart failure, and certain kidney conditions, and after heart attack, and are valued for their effects on long-term cardiovascular and renal outcomes. Common considerations in ACE inhibitor therapy include monitoring kidney function and blood potassium and recognizing side effects such as cough, and the class is often compared with related agents that act on the same hormonal pathway. Within Hypertension and Cardiology, ACE inhibitor therapy sits among the journal's coverage of blood pressure management and cardiovascular treatment. This page gathers peer-reviewed, open-access research relevant to the pharmacological management of hypertension and cardiovascular disease, supporting clinicians, researchers, and students concerned with how medicines targeting the renin-angiotensin system are used in patient care.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Ace Inhibitor Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hypertension and Cardiology (ISSN 2329-9487).

Journal editorial board
Hatori Nobuo · Japan Gregor Leibundgut · Switzerland Yuejin Li · United States

This page summarises published research for orientation; it is not medical or professional advice.